changes in liver. About 600 commercial preparations with liver protecting activity are available worldwide. In India, about 33% of herbal formulations available are used for liver protection and these preparations represent a variety of combinations of Indian medicinal plants. 1 There are not many liver protective drugs available that are also suitable for treatment. Diet, quality, and life habits are currently the only remedy for established disease. An actual curative therapeutic agent has not yet been found. Andrographis paniculata is one of the 19 species of the genus Andrographis (N.O. Acanthaceae) available in India. It is commonly seen growing with its allied species, the spice Andrographis echiodes Nees. The fresh and dried leaves of A. paniculata and the juice extracted from the shrub are official in Indian pharmacopoeia.
The aim of the present study was to investigate the effect of the active compound andrographolide on liver tumors. It was of interest to see whether supplementation of andrographolide has any effect in ameliorating the severe liver damage caused by technical grade hexachlorocyclohexane (benzene hexachloride or BHC). 2 A ncient health science, such as Ayurveda of India, depends on natural products. Ayurveda is still an active and important system of medicine in India. Many Ayurvedic herbal preparations have found their way in the pharmacopeias of different countries. With the advent of chemotherapy, several of these preparations are supplemented by more effective or less toxic synthetic drugs.
It is now generally felt that the bulk of the drugs in use are human made. Continuous use of such synthetic xenobiotic and therapeutic agents may affect the metabolic and excretory functions leading to secondary physiological changes in liver. Hepatocellular carcinoma (HCC) is one of the primary malignancies associated with physiological Relevance. The present investigation relates to the influence of andrographolide, an active compound of Andrographis paniculata Nees. It reverses an experimental liver carcinogenic condition of mice to normal and might be a potential therapeutic/preventive agent for human liver cancer. Objective. A. paniculata (Kalmegh) is extensively used in the Indian traditional system of medicine as a hepatoprotective and hepatostimulative agent and has been reported to have protective effect against different hepatotoxins. Materials and methods. Histomorphological, ultrastructural, and biochemical studies were performed for the effect of the andrographolide on control mice, mice treated with hexachlorocyclohexane (BHC) only and BHC + andrographolide. Enzymes for liver function tests were analyzed by spectrophotometric method. Results. The BHC experimental model forms an irreversible liver tumor in male mice. The histological and ultrastructural changes observed in andrographolide supplementation emphasize the recovery of the damaged liver. This recovery was also reflected in the neoplastic nodule formation. The activity of phosphorylase and glucose-6-phosphatase in the liver of the andrographolidesupplemented group suggests improved glycogenolysis in liver. Serum glutamate pyruvate transaminase, serum glutamate oxalate transaminase, alkaline phosphatase, acid phosphatase, and γ-glutamyl transpeptidase showed a significant decrease in andrographolide-supplemented animals as compared with BHC-treated animals, suggesting regenerative effects elicited by andrographolide. Conclusion. The study indicates that the regenerative capability elicited by andrographolide is possibly due to its ability to reactivate liver function enzymes that catalyze the reaction of several biochemical and synthetic processes and that it may be useful for severe liver damage conditions.
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Materials and Methods
Extraction of Active Compound
The andrographolide (a pure active compound) was obtained from the B.V. Patel Pharmaceutical Educational and Research Development (PERD) Centre, Ahmedabad. Andrographolide was administered in 3 doses: low (5 mg/ kg body weight), medium (7 mg/kg body weight), and high (10 mg/kg body weight).
Experimental Animals
Healthy, adult, pathogen-free, colony bred male albino mice (Mus musculus) of Swiss strain 1 month old weighing between 20 and 30 grams were used in this study.
Animal Ethics and Guidelines
The Indian Council of Medical Research Guideline for the care and use of laboratory animals was followed.
Experimental Tumor Model
Technical grade of BHC was used for inducing a carcinogenic condition in the liver of male mice. [3] [4] [5] 
Treatment Diet
The BHC-treated animals were given a basal diet with BHC 500 ppm/kg food. This dose approximates the highest tolerable limit causing significant mortality in test animals. 5 The BHC insecticide was weighed and dissolved in alcohol and homogeneously mixed in the diet; the alcohol was allowed to evaporate by drying. The dose of BHC 500 ppm/kg food was selected on the basis of previous work on rodents. [3] [4] [5] 
Experimental Design
Group I (control, n = 50), group II (BHC-treated for carcinogenic condition, n = 50), group III (BHC-treated animals supplemented with andrographolide-supplemented group, n = 150), and group IV (positive control group, supplemented with andrographolide only, n = 50) animals were used for the study. Various groups of animals, treatment, and duration (months) are given in Table 1 . All the animals were anesthetized with ether to collect blood from the retro-orbital sinus. After blood collection, animals were killed by cervical dislocation and liver was dissected for other histological and biochemical studies. In each group, 6 animals were sacrificed monthly for 8 months for biochemical and morphological analysis.
Morphological Study
At the end of each treatment, the animals were weighed on an animal balance for total body weight whereas organ weight was measured after the animals were sacrificed.
Source of Chemicals and Reagents
All the chemicals used for histomorphological and biochemical analysis were of analytical grade. The rare chemicals were obtained from Sigma (St Louis, MO), BDH (Poole, UK), Fluka (Buchs, Switzerland), E. Merck (Darmstadt, Germany), HiMedia (Mumbai, India), SRL (Mumbai, India), Loba Chemie (Mumbai, India, and Qualigen (Mumbai, India). All the solutions were prepared according to the specified standard methods and conditions required.
Histological Method
The dissected liver was fixed in Bouin's fixative; wax blocks were prepared and thin section of 5 to 7 µm thickness were prepared using a microtome and mounted on adhesive-smeared glass slides. The sections were stained for hematoxylin and eosin stain. The histological studies of the mice liver were performed using light microscopy.
Ultrastructural Study
The ultrastructural studies of the mice liver were performed using glutaraldehyde and osmium tetrachloride fixation, uranyl acetate, and lead citrate staining. The sections were studied under transmission electron microscopy.
Biochemical Methods
All the biochemical methods were performed at the Department of Zoology laboratory using a Beckman DU40 spectrophotometer. The protein content in liver tissue of mice was estimated according to the method of Lowry et al. 6 Blue color developed with phenol reagent of Folin-Ciocalteu reagent was spectrophotometrically measured and expressed as mg/g body weight. Serum glutamate pyruvate transaminase (SGPT) and oxalate transaminase (SGOT) assays were carried out from serum samples according to the method of Reitman and Frankel. 7 The serum was allowed to act in a buffered solution of ketoglutaric acid. Alanine and l-aspartate were, respectively, used as specific substrate for SGPT and SGOT. Formazan produced a colored complex with 2,4-dinitrophenyl hydrazine, which was measured spectrophotometrically. The values were expressed in µKat/L. The activity of alkaline phosphatase (ALP) was carried out from tissue samples as described by Kind and King. 8 ALP acts in alkaline condition with p-nitrophenyl phosphase (PNPP) to liberate phosphate group and gives p-nitrophenyl (PNP), which was measured at 410 nm by spectrophotometer. The unit was expressed as µmol p-nitrophenol released/ min/mg protein. The activity of glucose-6-phosphatase (G-6-Pase) was determined by the method of Swanson. 9 Standard PO 4 (phosphate) concentration (10 × 10 −6 M) was used for calculation of activity and G-6-Pase was expressed in terms of the amount of µmol inorganic phosphate formed/h/mg protein. Glycogen was determined using the anthrone reagent as described by Seifter et al. 10 Anthrone was dissolved in concentrated sulfuric acid. This solution was cooled and maintained on ice. Anthrone reagent was added to glycogen extracted from muscles or to standard glycogen solutions. Tubes were maintained on ice and the anthrone reagent was added with continuous stirring. After this, tubes were put in boiling water for 10 minutes. Color was read at 620 nm. γ-Glutamyl transpeptidase (γ-GTPase) activity was assayed by the method of Tate and Meister. 11 The assay mixture consisted of γ-glutamyl-p-nitroanilide, glycyl glycine, TRIS-HCl buffer. The release of p-nitroanilide was recorded at 410 nm at 37°C. The enzyme activity was expressed as units/min/ mg protein, where 1 unit of γ-GTP is equivalent to the µmol of p-nitroanilide released per minute (ε for p-nitroaniline = 8800 M −1 cm −1 ). The ornithine carbamoyltransferase (OCT) activity was estimated in liver by the method of Raijman. 12 Citrulline formed from the substrate was kinetically monitored and OCT activity was expressed as unit/min/g fresh liver tissue. One unit of OCT is equivalent to the µmol of citrulline synthesized per minute.
Citrulline (100 µmol) was used as a standard. The phosphorylase activity was assayed by the method of Cori et al. 13 The enzymatic activity was expressed as µmol phosphorus released/15 min/mg protein. Inorganic potassium phosphate solution was used as a standard. The activity of adenosine triphosphatase (ATPase) in the liver was assayed by the method of Quinn and White. 14 
Statistical Method
Data were statistically analyzed using the SPSS statistical software package (version 13). Student's t test was performed to compare enzyme activities between the groups. Data were considered statistically significant when P values were ≤.05.
Results
Morphological Findings
The morphological changes observed in the mice liver are shown in Figures 1A to 1D . The mice treated with BHC (group II) for 8 months showed liver tumor formation ( Figure 1B ) as compared with group I control mice liver ( Figure 1A ). Mice treated with BHC + andrographolide for 6 months (group III; Figure 1C ) show reversible changes in tumor morphology, which were comparable with group I control mice liver ( Figure 1A ). Mice treated with only andrographolide as a positive control (group IV, Figure 1D ) were comparable with negative controls ( Figure 1A ).
Histological Findings
The liver histology of control mice from group I and positive control group IV showed normal arrangement of hepatocytes with clearly brought out nuclear, central vein, portal tract, which contains terminal portal venule, and hepatic arteriole, bile duct, sinusoids, and Kuffer cells (Figures 2A and 2D , respectively). The parenchyma around the central vein had disaggregated basophilic bodies resulting in a diffuse basophilic cytoplasm. There were few clear cells around the peripheral region that started appearing with dislocated basophilic bodies. In 2-month BHC-treated mice liver in group II, the liver lesions were distinct in the acinus peripheral and acinus central; a few clear cells appeared with dislocation of basophilic bodies. The nuclei of the clear cells were often characterized by an increase in the condensed chromatin. Most acidophilic cells were larger than the clear cells ( Figure 2B ). Livers that were BHC-treated for 4 months showed small to large hepatocytes with enlarged nucleus and larger nucleoli ( Figure 2C ). These are focal nodular proliferation of somewhat altered liver cells appearing during the neoplastic phase. Neoplastic nodules originating from liver parenchyma appeared within 6 months after BHC treatment ( Figure 3A ). These expanding nodules compressed the surrounding liver parenchyma. After 6 to 7 months, BHC-treated liver showed severe liver damage and well-differentiated hepatocellular carcinoma ( Figure 3B ). At a later stage (8-month BHC-treated), typical hepatocellular carcinoma was observed in mice ( Figure 3C ). The tumor cells are arranged in pseudoacinus or granular pattern. In group III, BHC + andrographolide (7 mg, 10 mg) for different months, histological changes were observed. The liver lesions seen after 2 months of BHC + andrographolide (7 mg and 10 mg) do not have many changes observed as compared with BHC alone. The liver cells appeared cytologically quite normal ( Figure 2E ). Hepatic cells and radial pattern were not disturbed compared with 2-month BHC-treated mice. Successive improvement was seen after supplementation with andrographolide. The above-mentioned liver damage was less severe in animals supplemented with andrographolide (10 mg) for 4 months in group III compared with BHC-treated group for the same period. Liver cells were quite normal; few clear cells were observed. But preneoplastic nodules were not observed clearly in andrographolide-supplemented mice liver ( Figure 2F ). In liver lesion after 6 months andrographolide supplementation (10 mg) in group III, morphological changes like acidophilic cells, basophilic cells, and few clear cells were also observed ( Figure 3D ). Cellular vacuolization and fat deposition were observed ( Figure 3E ). Neoplastic nodules were not visible, which were observed in 6-month to 7-month BHC-treated (group II) mice.
It was further observed that after 8 months of andrographolide (10 mg) supplementation in mice liver, many distinct changes were indicated, including acidophilic cells, basophilic cells, few clear cells, and cellular vacuolization. However, neoplastic nodules were not visible ( Figure 3F ), which were observed in group II (6 months BHC alone). A fully tumorous condition was observed when BHC was given for 7 to 8 months.
Ultrastructural Study
In addition to the histology, in-depth electron microscopy study was also undertaken to find out the ultrastructural condition due to severe hepatic damage with BHC treatment (group II) and the effect of supplementation with andrographolide with different doses, that is, at 7 mg and 10 mg (group III), at the subcellular level. The electron microscopic observation of liver tissue from control animals showed polyhedral hepatic cells having 1 or 2 nuclei ( Figure 4A ). The entire mass of the liver cell was surrounded by bands of collagenous fibrils. Mitochondria were abundant and polymorphic. The hepatic cells contained numerous mitochondria, stored glycogen, and small electron dense bodies called lysosomes, most of which were located around the bile canaliculi. The surface of the bile canal was covered by small microvilli. The nucleus occupied a large middle part of the cell with nuclear chromatin material concentrated at the nuclear periphery. The surrounding area was covered by abundant mitochondria. Elements of rough endoplasmic reticulum (RER) were scattered throughout the cytoplasm ( Figure 4B ).
The prominent ultrastructural changes observed in BHC-fed animals after 4 months (group II) included fatty deposition and increased glycogen contents. The nucleus shape and size and chromatin material appeared normal. The RER and structure of mitochondria were normal ( Figures 5A to 5C ). After 6 month of BHC treatment, the hepatocyte cytoplasm showed numerous swollen mitochondria with changes in the structure of cristae. Excessive fat droplets were also present. The cytoplasm showed dense aggregation of glycogen and excessive vacuolization, which gave an empty appearance of the cell. At a few places the hepatic cell also contained lamellae-like structures, RER in which the ribosomes appeared to be detaching from the membrane surface. The hepatic cell nucleus further showed chromatin disorganization ( Figures 6A to 6E) .
Within 8 months of BHC treatment ( Figures 7A to  7D) , the hepatocytes showed dense aggregation and clumping of glycogen near the nucleus and surrounding the other areas. The size and shape of mitochondria were changed. At some places, mitochondria were enlarged with lack of cristae; the cristae were broken with their membrane ruptured or disintegrated. The hepatic cell nucleus chromatin showed disorganization. The most prominent changes were observed in the cytoplasm, including pronounced diffuse proliferation of smooth endoplasmic reticulum (SER). These well-known changes of the cytoplasmic fine structure are responsible for the acidophilic appearance of the respective hepatocytes in the light microscopy. At some places, hepatic cells also contained lamellar RER in which the ribosomes appeared to be detaching from the membrane surface.
The ultrastructural changes in 4-month treated liver of group III, which was supplemented with andrographolide (7 mg and 10 mg) along with BHC, included hepatocytes showing near recovery at the cellular level. The structure of hepatocytes was almost normal and total recovery was observed corresponding to 4 months of BHC treatment (group II, Figures 5D and 5E ). In the electron micrographs of 6-month andrographolide supplementation (high dose 10 mg) group III, partial recovery is shown ( Figures 6F to 6I) . The size, structure, and surface area of mitochondria were normal compared with 6-month treatment with BHC alone. Nucleolus and nuclear membrane appeared normal. The cells showed vacuolization at some places and glycogen granules were present in some places but partial recovery was observed as compared with 6 months of treatment with BHC alone. The RER were normal, cisternae were parallel, and ribosomes were attached with RER.
The 8-month andrographolide-supplemented (group III, 10 mg) mice showed reasonable recovery compared with the 8-month BHC treatment group (Figures 7E to  7H) . The ultrastructure of hepatocytes showed clear nuclear membrane. The cell showed lamellar RER and SER, and ribosomes were present on the RER. The cell showed few fat droplets, vacuolization, and glycogen clumping.
Biochemical Studies
Protein, G-6-Pase, phosphorylase, ATPase, and SDH levels.
The changes in the levels of protein, G-6Pase, phosphorylase, ATPase, and SDH in the liver of groups I to IV at different months are depicted in Figures 8A to 8E . The level of liver protein, G-6Pase, phosphorylase, ATPase, and SDH in BHC-treated (carcinogenic) mice (group II) decreased as compared with the control (group I), whereas group III (BHC + andrographolide) showed a considerable increase as compared with the corresponding group II. In group IV, the levels of protein, G-6Pase, phosphorylase, ATPase, and SDH did not show significant changes as compared with those of group I.
Glycogen, SGPT, SGOT, ALP, ACP, γ-GTP, and OCT levels. Glycogen, SGPT, SGOT, ALP, ACP, γ-GTP, and OCT levels in the liver of groups I to IV at different months are shown in Figures 9A to 9G . The glycogen, SGPT, SGOT, ALP, ACP, γ-GTP, and OCT levels in liver were significantly increased in group II as compared with control (group I). The quantitative results on the levels of glycogen, SGPT, SGOT, ALP, ACP, γ-GTP, and OCT in the andrographolide-supplemented (group III) mice show a remarkable decrease compared with group II. The positive controls (group IV) showed no significant changes in the said biochemical markers as compared with controls (group I).
Discussion
A number of changes have been observed in the liver as a result of toxic effects of chemicals. The liver is the first organ in which investigations of dose response relationships in chemicals carcinogenesis were carried out systematically. 17 The determination of the induction and the total dose required for the production of liver tumors by different hepatocarcinogens led to the well-known concept of Druckrey 18 that the primary carcinogenic effects of all individual doses act additively to form the final tumor. No liver tumor was developed in animals immediately after 2 months of BHC exposure. However, tumors appeared after BHC treatment for longer duration of time and maximum tumor developed after 8 months of BHC treatment. The results of the present study indicate a dose dependence relationship with incidence of tumors as suggested by Druckrey 18 and James et al. 19 The present study shows considerable changes in functional markers and growth behavior of abnormal hepatocytes at several stages of liver carcinogenesis after BHC treatment. The most important characteristic of early HCC lesion due to BHC treatment has the following 5 characteristics that were also observed by others 20 : increased cell density associated with the increase of nucleus/cytoplasm ratio, increased eosinophilic staining affinity, fatty changes and clear cells changes, irregular thin trabecular pattern, and acinar and pseudoglandular patterns.
In general, cytoplasmic changes have been observed. There is increased basophilic or eosinophilic cytoplasmic staining, which may be of diagnostic use. 21 For unknown reasons, tumor cells have a remarkable tendency to undergo fatty changes or clear cells alterations, especially in small nodules. Similar findings were also observed by Kojiro et al. 22 In this study, BHC-treated liver showed small to large hepatocytes with enlarged nucleus and bigger nucleoli. At a later stage, these lesions turn into preneoplastic nodules, similar to the ones observed by Williams. 23 The preneoplastic lesion of the liver has been analyzed histologically and the reversibility or irreversibility of preneoplastic or neoplastic changes has been discussed extensively by Bannasch et al. 24 The histological changes observed in the present study also reveal that the lesions in liver are multifocal in origin and progressive in nature. This finding supports the earlier observations. 3, 4, 25, 26 Early preneoplastic lesions observed after 2, 4, 6, and 8 months of BHC exposure consisted mainly of clear cells, acidophilic cells, and cells with larger nuclei. However, these changes became reversible with andrographolide treatment. The 2-month BHC + andrographolide supplemented animals showed few changes compared with the group treated with BHC alone. The hepatocytes appeared cytologically quite normal. Hepatic cells and radial pattern were not disturbed compared with corresponding 2, 4, 6, and 8 months treatment with BHC alone (group II). Preneoplastic nodules were not observed clearly in 4, 6, and 8 months andrographolide-supplemented animals in group III. Successive improvement at the cellular level in hepatocytes may be due to the effects of andrographolide.
The ultrastructural study of the liver showed various changes in different groups. The shape and structure of mitochondria were altered considerably in 6-month to 8-month BHC-treated animals. ATPase is an important group of mitochondrial enzymes, which controls the energy metabolism of the body and its cation transport. ATPase showed a significant decline in its activity after BHC administration in experimental group II. Similarly, Bhatt et al 27 have shown that the neoplasms and tumors have less ATPase activity as compared with normal animals. Toskulko and Glinsukon 28 have reported increased accumulation of Ca + inside mitochondria causing mitochondrial dysfunction and reduction in hepatic ATP content. The activity of SDH, a key enzyme of the mitochondrial Krebs cycle, showed a significant decline during BHC treatment. This could be due to reduction in oxygen transport to the tissues. The hepatocytes of the BHC exposed mice were studied ultrastructurally, and show swollen mitochondria and lack of cristae. Our data corroborates with the findings of histoenzymology study on SDH activity in BHC induced rat liver by Nigam et al. 3 Inhibition of liver mitochondria and electron transport flow by aflatoxin has been reported in the rat. 29 The SDH activity was increased in group III as compared with the BHC-treated group II.
Excessive accumulation of glycogen was found within the cytoplasmic matrix in BHC treated hepatocytes. It is suggested that these changes may be due to enhanced glycogenesis or inhibition of glycogenolysis, which may be a consequence of a toxically induced enzyme deficiency. The reduced activities of phosphorylase and G-6-Pase suggest that these enzymes play an important role in the glycogenolysis and origin of carcinogen-induced glycogenesis. This reduced activity of the enzyme G-6-Pase was also described earlier by Karnik et al. 30 The activity of G-6-Pase significantly increased in group III. Kataria et al 31 have reported that G-6-Pase activity had decreased activity in CCl 4 -treated rats but the drug Liv-52 significantly stimulated G-6-Pase activity in response to CCl 4 toxicity. It seems that andrographolide provides a certain amount of protection and has the capacity to correct liver dysfunction.
The most prominent change was observed for diffuse proliferation of SER. This well-known change of the cytoplasmic fine structure is responsible for the acidophilic appearance of the respective hepatocytes, which were observed in light microscopy. The granular or rough ER also plays an important role in hepatocarcinogenesis. 3 The outstanding feature of the acidophilic cells is a pronounced proliferation of the agranular endoplasmic reticulum. Earlier study on BHC-exposed mice showed hypertrophy of the SER. It was always preceded by enhanced glycogen storage and thus indicative of a direct or indirect relation between agranular ER and glycogen in hepatocytes. It was also suggested that hypertrophy of agranular ER is the consequence of an impaired carbohydrate metabolism, which was a common feature in hepatocarcinogenesis. Similarly, concentric whorls of the ER are associated with a decreased in the synthesis of phospholipids and that happens either by desynchronization of the synthesis of protein and phospholipids or due to some other mechanism involved in lipid protein interaction in hepatocytes exposed to various hepatocarcinogens. 32 A significant decrease in protein content during hepatocarcinogenesis was also seen in various types of liver tumors. 33 Many earlier reports have shown changes in protein after pesticide exposure. 34 Concentric arrangement of lamellar cisternae complex of the agranular reticulum as described in this study has also been reported earlier study on BHC by Ito et al. 32 Ultrastructurally, when vacuolated cells were examined under the electron microscope, they showed a large amount of lipid/fat droplets in their cytoplasm. It is presumed that inhibition of protein synthesis and consequent impairment of lipoprotein formation resulted in accumulation of fat mainly triglycerides with ER and smooth membrane bound vacuoles, which coalesced to form large lipid droplets in cytoplasmic matrix. 35 The loss of canalicular microvilli as observed is suggestive of abnormality in the transport and canalicular secretion of bile.
SGPT and SGOT have been extensively studied during acute or chronic intoxication of the liver. 36 The results obtained in this extensive study indicate a significant increase of serum enzyme (transferases). SGPT and SGOT both were elevated in BHC-treated (group II) as compared with control (Group I) animals. On the other hand, in animals that were supplemented with andrographolide in group III, the activities of both SGOT and SGPT decreased drastically. Earlier researchers have shown that the rise in SGPT and SGOT levels were reduced by Jigrin, a herbal drug, 37 turmeric, 38 and Acacia catechu. 39 In the present study, ALP activity in liver tissue was increased significantly in BHC-treated group II mice from 1 month to 8 months. It is also reported that the ALP activity increased many fold in the neoplastic nodule of the liver after continuous feeding of technical grade BHC to inbred Swiss mice as well as in benign and malignant nodules. 40 A decline in enzyme level in hepatic cells suggests protective effect on the liver. This finding is in conformation with earlier reports by Zimmerman and Seet. 41 The level of ALP decreased in the andrographolide-supplemented group III; this result may suggest that andrographolide restores plasma membrane permeability, including the repair of injured hepatic cells. Koul and Kapil 42 also reported decreased ALP activity with administration of diterpenses of A. paniculata on CCl 4 -damaged liver.
A number of drugs and chemicals are known to increase γ-GTP activity by the induction of microsomal enzymes. 43 The present study showed a significant increase in activity of γ-GTP after BHC exposure. Such multifold increase in chemically induced rat hepatoma has been reported earlier. 44 The γ-GTP activity significantly decreased in supplemented group III, which could be indicative of the membrane stabilizing activity of andrographolide. The hepatoprotective property of silymarin has been related to the inhibition of γ-GTP, and a decrease of γ-GTP activity was reported. 45 Similarly, OCT is involved in urea synthesis, and therefore is considered as an important hepatospecific enzyme. Thakore 46 studied human workers exposed to BHC in both handler groups and nonhandler groups, and significant increase in OCT was found in the BHC handler group. The OCT activity increases after BHC treatment as compared with the control group. This is due to hepatocellular damage or increased permeability of liver cells. On the contrary, in group III, which was BHC exposed and supplemented with andrographolide, there was a significant decrease observed in the OCT activity as compared with the BHC treatment alone (group II).
A hydrolytic enzyme such as ACP is the prime candidate for the tissue reorganization and tissue repair. Intracellularly, ACPase is restricted to the membrane bound vesicle lysosomes. In the present study, activity of ACPase was significantly increased in group II (BHC exposure) that was normalized on andrographolide treatment in group III. Rise in ACPase activity can be due to effect of BHC toxicity on hepatocytes causing permeability alterations, leakages of lysosomal enzyme, and lysis of the cell causing enhanced release of this enzyme. Kohle 47 has reported that ingestion of aflatoxin-contaminated feed caused increased activity of ACP.
